9999999997-18-007391.txt : 20180821 9999999997-18-007391.hdr.sgml : 20180821 20180821160814 ACCESSION NUMBER: 9999999997-18-007391 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180821 DATE AS OF CHANGE: 20180821 ACTION DATE: 20180821 RECEIVED DATE: 20180821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-183706 FILM NUMBER: 181030449 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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